Mars Veterinary Executive and Leadership Team

Jan Freudenberg, the Chief Financial Officer at Mars Veterinary, directs financial strategy and operations for the organization. Freudenberg oversees all fiscal activities, including budgeting, financial planning, and reporting, ensuring robust financial health across the global network of clinics. This leadership role involves managing investments in innovation and technology to support the company's mission of improving pet health. Freudenberg's oversight extends to optimizing financial performance to enable the expansion of veterinary services and support for veterinary professionals. The focus remains on driving sustainable growth and ensuring the efficient allocation of resources to achieve strategic objectives. Freudenberg's financial acumen supports the organization's commitment to high-quality preventive, general, specialty, and emergency care.

Tatsuhiko Miyamoto, the Chief Financial Officer, At Vca (Japan) at Mars Veterinary, manages the financial landscape for VCA operations within Japan. Miyamoto's responsibilities encompass the financial health and strategic fiscal planning specific to the Japanese market, aligning with global financial directives. This role involves detailed analysis of regional financial performance, identifying opportunities for growth, and ensuring compliance with local financial regulations. Miyamoto supports the expansion of veterinary services in Japan, contributing to the overall mission of enhancing pet wellbeing. The financial oversight provided by Miyamoto is crucial for sustaining high-quality care and supporting veterinary professionals in the region. Miyamoto's expertise ensures the effective management of financial resources to drive operational excellence and contribute to the company's global objectives.

Edwin Stedem, the Global Chief Financial Officer, Mars Veterinary Health at Mars Veterinary, directs the comprehensive financial strategy and operations across the entire global veterinary health organization. Stedem's purview includes overseeing all fiscal activities, from budgeting and financial planning to reporting and investment strategies, ensuring the financial stability and growth of over 3,000 clinics worldwide. This critical leadership position involves leveraging advanced technologies and extensive data to enhance veterinary care and support the nearly 70,000 associates. Stedem's financial guidance is instrumental in driving innovation and scientific breakthroughs, directly impacting the company's mission to create a better world for pets and their caregivers. The financial oversight ensures efficient resource allocation for preventive, general, specialty, and emergency care services. Stedem's strategic financial management supports the wellbeing of pets and the professionals dedicated to their care.

Todd Tams, the Chief Medical Officer, External Affairs at Mars Veterinary, leads the medical strategy and external engagement initiatives for the organization. Tams oversees the clinical direction and ensures the highest standards of veterinary care are maintained across the global network of clinics. This role involves fostering relationships with external stakeholders, including veterinary associations and research institutions, to advance the science of animal health. Tams champions innovation and the implementation of cutting-edge medical practices, aligning with the company's commitment to improving pet health and wellbeing. The focus is on translating scientific breakthroughs into practical applications that benefit pets and support veterinary professionals. Tams's leadership ensures that Mars Veterinary remains at the forefront of medical excellence and contributes positively to the broader veterinary community. External affairs strategy under Tams supports the organization's mission and enhances its global reputation.